119 related articles for article (PubMed ID: 8239513)
1. Cytogenetical observations in nine ocular malignant melanomas.
Dahlenfors R; Törnqvist G; Wettrell K; Mark J
Anticancer Res; 1993; 13(5A):1415-20. PubMed ID: 8239513
[TBL] [Abstract][Full Text] [Related]
2. Clinical and cytogenetic analyses in uveal melanoma.
Kilic E; van Gils W; Lodder E; Beverloo HB; van Til ME; Mooy CM; Paridaens D; de Klein A; Luyten GP
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3703-7. PubMed ID: 16936076
[TBL] [Abstract][Full Text] [Related]
3. Molecular cytogenetic analysis of archival uveal melanoma with known clinical outcome.
Mensink HW; Kiliç E; Vaarwater J; Douben H; Paridaens D; de Klein A
Cancer Genet Cytogenet; 2008 Mar; 181(2):108-11. PubMed ID: 18295662
[TBL] [Abstract][Full Text] [Related]
4. Chromosomal gains and losses in uveal melanomas detected by comparative genomic hybridization.
Speicher MR; Prescher G; du Manoir S; Jauch A; Horsthemke B; Bornfeld N; Becher R; Cremer T
Cancer Res; 1994 Jul; 54(14):3817-23. PubMed ID: 8033101
[TBL] [Abstract][Full Text] [Related]
5. Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma.
Aalto Y; Eriksson L; Seregard S; Larsson O; Knuutila S
Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):313-7. PubMed ID: 11157859
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions.
Koopmans AE; Ober K; Dubbink HJ; Paridaens D; Naus NC; Belunek S; Krist B; Post E; Zwarthoff EC; de Klein A; Verdijk RM;
Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):6024-30. PubMed ID: 25159205
[TBL] [Abstract][Full Text] [Related]
7. Acquired homozygosity (isodisomy) of chromosome 3 during clonal evolution of a uveal melanoma: association with morphologic heterogeneity.
White VA; McNeil BK; Thiberville L; Horsman DE
Genes Chromosomes Cancer; 1996 Feb; 15(2):138-43. PubMed ID: 8834179
[TBL] [Abstract][Full Text] [Related]
8. Characterization of complex chromosomal abnormalities in uveal melanoma by fluorescence in situ hybridization, spectral karyotyping, and comparative genomic hybridization.
Naus NC; van Drunen E; de Klein A; Luyten GP; Paridaens DA; Alers JC; Ksander BR; Beverloo HB; Slater RM
Genes Chromosomes Cancer; 2001 Mar; 30(3):267-73. PubMed ID: 11170284
[TBL] [Abstract][Full Text] [Related]
9. Expression of p53-induced apoptosis effector PERP in primary uveal melanomas: downregulation is associated with aggressive type.
Paraoan L; Gray D; Hiscott P; Ebrahimi B; Damato B; Grierson I
Exp Eye Res; 2006 Oct; 83(4):911-9. PubMed ID: 16784742
[TBL] [Abstract][Full Text] [Related]
10. Tumor classification based on gene expression profiling shows that uveal melanomas with and without monosomy 3 represent two distinct entities.
Tschentscher F; Hüsing J; Hölter T; Kruse E; Dresen IG; Jöckel KH; Anastassiou G; Schilling H; Bornfeld N; Horsthemke B; Lohmann DR; Zeschnigk M
Cancer Res; 2003 May; 63(10):2578-84. PubMed ID: 12750282
[TBL] [Abstract][Full Text] [Related]
11. Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma.
Maat W; Ly LV; Jordanova ES; de Wolff-Rouendaal D; Schalij-Delfos NE; Jager MJ
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):505-10. PubMed ID: 18234992
[TBL] [Abstract][Full Text] [Related]
12. Multiplex fluorescence in situ hybridization identifies novel rearrangements of chromosomes 6, 15, and 18 in primary uveal melanoma.
Sisley K; Tattersall N; Dyson M; Smith K; Mudhar HS; Rennie IG
Exp Eye Res; 2006 Sep; 83(3):554-9. PubMed ID: 16684523
[TBL] [Abstract][Full Text] [Related]
13. Association of specific chromosome alterations with tumour phenotype in posterior uveal melanoma.
Sisley K; Parsons MA; Garnham J; Potter AM; Curtis D; Rees RC; Rennie IG
Br J Cancer; 2000 Jan; 82(2):330-8. PubMed ID: 10646885
[TBL] [Abstract][Full Text] [Related]
14. Regression of uveal melanoma after plaque radiotherapy and thermotherapy based on chromosome 3 status.
Shields CL; Bianciotto C; Rudich D; Materin MA; Ganguly A; Shields JA
Retina; 2008 Oct; 28(9):1289-95. PubMed ID: 18628721
[TBL] [Abstract][Full Text] [Related]
15. Major cytogenetic aberrations and typical multidrug resistance phenotype of uveal melanoma: current views and new therapeutic prospects.
Baggetto LG; Gambrelle J; Dayan G; Labialle S; Barakat S; Michaud M; Grange JD; Gayet L
Cancer Treat Rev; 2005 Aug; 31(5):361-79. PubMed ID: 15994016
[TBL] [Abstract][Full Text] [Related]
16. Genetic study of familial uveal melanoma: association of uveal and cutaneous melanoma with cutaneous and ocular nevi.
Smith JH; Padnick-Silver L; Newlin A; Rhodes K; Rubinstein WS
Ophthalmology; 2007 Apr; 114(4):774-9. PubMed ID: 17207529
[TBL] [Abstract][Full Text] [Related]
17. Nonrandom chromosomal abnormalities in primary uveal melanoma.
Prescher G; Bornfeld N; Becher R
J Natl Cancer Inst; 1990 Nov; 82(22):1765-9. PubMed ID: 2231772
[TBL] [Abstract][Full Text] [Related]
18. Non-random abnormalities of chromosomes 3, 6, and 8 associated with posterior uveal melanoma.
Sisley K; Cottam DW; Rennie IG; Parsons MA; Potter AM; Potter CW; Rees RC
Genes Chromosomes Cancer; 1992 Oct; 5(3):197-200. PubMed ID: 1384670
[TBL] [Abstract][Full Text] [Related]
19. Detection of genetic prognostic markers in uveal melanoma biopsies using fluorescence in situ hybridization.
Naus NC; Verhoeven AC; van Drunen E; Slater R; Mooy CM; Paridaens DA; Luyten GP; de Klein A
Clin Cancer Res; 2002 Feb; 8(2):534-9. PubMed ID: 11839674
[TBL] [Abstract][Full Text] [Related]
20. Establishment and characterization of two uveal melanoma cell lines derived from tumors with loss of one chromosome 3.
Nareyeck G; Zeschnigk M; Prescher G; Lohmann DR; Anastassiou G
Exp Eye Res; 2006 Oct; 83(4):858-64. PubMed ID: 16750193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
